Imagine this: It's the holiday season, and instead of diving into overflowing plates of festive feasts, you're taking tiny bites and strategically 'pregaming' to keep the celebration going without derailing your weight loss journey. For many on GLP-1 medications in Long Island, this isn't just a choice—it's a new reality that's sparking both admiration and heated debate. But here's where it gets intriguing: Are these drugs a game-changer for holiday joy, or are they just masking deeper habits? Let's dive in and explore how folks are navigating the season with wit and wisdom.
Take Linda McMahon, a 57-year-old from Patchogue, who shared a hearty laugh about her Thanksgiving gathering dubbed the 'Mounjaro crew'—a group of pals all riding the GLP-1 wave. 'If you'd peeked at our plates, you'd have cracked up,' she recalled. Gone were the towering stacks of ham, creamy mashed potatoes, and classic green bean casserole; in their place were modest portions of everything. 'I didn't even glance at the bread,' McMahon admitted, though she did indulge in some refreshing pumpkin ale.
As the calendar fills with holiday bashes, family reunions laden with abundant spreads, and endless pours of wine and cocktails, the merrymaking poses a unique hurdle for the swelling ranks of individuals using GLP-1 drugs such as Wegovy, Ozempic, and Mounjaro. These medications have propelled remarkable weight reductions for countless users. Some opt for dainty servings and permit themselves an occasional indulgence. Others 'pregame' by munching on nutritious snacks beforehand. And then there's the camp that pauses their doses for a week or two, claiming it lets them relish the festivities more freely.
Dr. Michael Kaplan, a board-certified obesity medicine specialist and co-founder of the Long Island Weight Loss Institute (liwli.com), weighs in with a straightforward take: 'When counseling my patients, I remind them that Thanksgiving, Christmas Eve, and Christmas are just single days—I don't fuss much about their menus,' he said. 'But ditching the meds that are aiding them? That's often counterproductive.' McMahon herself has shed an impressive 112 pounds over three years on these drugs. 'I'm in top shape and feeling fantastic,' she beamed. 'I still embrace life; I just nibble a bit, and that's plenty.'
And this is the part most people miss: GLP-1 drugs, or Glucagon-like peptide-1 receptor agonists, mimic hormones your body naturally produces after eating. For beginners, think of it as a helpful signal that makes you feel less ravenous and satisfied longer because your digestion slows down. Initially crafted for diabetes patients, some of these meds are now sanctioned for obesity management, fueling a massive surge in popularity alongside worries over availability and escalating insurance premiums.
Expenditure on GLP-1 receptor agonists skyrocketed from $13.7 billion in 2018 to $71.7 billion by 2023, per a recent JAMA Network Open report (jamanetwork.com/journals/jamanetworkopen/fullarticle/2832114#250239372). Meanwhile, a tracking survey from last month by the nonprofit KFF (kff.org/public-opinion/poll-1-in-8-adults-say-they-are-currently-taking-a-glp-1-drug-for-weight-loss-diabetes-or-another-condition-even-as-half-say-the-drugs-are-difficult-to-afford/) revealed that 1 in 8 adults are currently using a GLP-1 drug, and 1 in 5 have tried one for weight loss, diabetes, or other chronic issues.
Common drawbacks include nausea, vomiting, and diarrhea, though many report none at all. Adjusting the dosage or switching types can often alleviate these for others, as patients have shared. Kaplan puts it eloquently: 'These meds silence the constant food chatter in your head. The sense of deprivation vanishes... so instead of polishing off a huge slice of lasagna, you might take a couple of bites and feel utterly content.'
But here's where it gets controversial: Is relying on 'pregaming' or tiny portions a sustainable way to celebrate, or does it risk turning holidays into a calculated game? For instance, some users skip doses temporarily, which doctors like Kaplan warn against—yet others swear by it for balance.
Bring Your Own Feast, or BYOF, is a smart tactic for Tamara Oliver, a 58-year-old vegan mom of triplets from Selden who's on Zepbound. She carts her own dishes to friends' or family's homes and scans menus ahead of restaurant outings. Through workouts and two GLP-1 meds, she's dropped nearly 90 pounds in three years, bidding farewell to her debilitating sciatica pain. Still, she grants herself rare tastes of the off-limits, like the non-vegan peppermint bark gifted last Christmas. 'Goodness gracious!' she exclaimed, remembering her surprise at its deliciousness. 'I sampled some, then more, and felt a twinge of regret—but perfection isn't the goal. It's alright.' Oliver experienced no side effects on Mounjaro or Zepbound, but a compounded version during shortages made her terribly sick with stomach woes.
Critics often question the long-term viability of GLP-1s, wondering if they're a quick fix. 'It's akin to any lifestyle shift,' Oliver noted. 'You must still put in effort, choose wisely, and be gentle with yourself. Those fundamentals remain unchanged.'
Ingrid Dodd, a 57-year-old from Lido Beach running a PR and digital marketing firm, attests that GLP-1s have revolutionized her holiday vibe—for the better. 'I used to agonize over December's onslaught of parties and booze, obsessed with food,' she confessed. 'Now, it's pure enjoyment.' She 'pregames' with a protein shake, stays hydrated for better digestion, and stays active to maintain her weight. 'I prioritize bone health and protein intake under medical guidance,' she explained. 'This isn't DIY; you need an expert.' Dodd hasn't forsaken her go-to espresso martini with Baileys—she just savors it slowly all evening.
Senior Nurse Practitioner Faina Norinskiy, overseeing the bariatric program at Long Island Jewish Valley Stream, emphasizes that cuisine is central to holiday cheer, and that's fine. 'We aim to keep them included,' she said. 'For dinner parties, I suggest balancing meals with quality protein to curb temptations.' She encourages confidence in accepting or declining portions. 'No need for three pie slices; a few bites suffice, then set it aside. Folks fret about judgment.' Some inquire about pausing doses for bigger indulgences, but Norinskiy advises otherwise. 'They can savor the treats—just in smaller amounts,' she recommended.
That approach resonates with Christine Bond, a 57-year-old from Queens, who savors her favorites on GLP-1 meds with a key tweak. 'I adore ice cream, but now a single scoop hits the spot, and I'm content,' she said. No gut issues for her, though she boosts fiber for smooth digestion. At holiday feasts, she'll try sweet potato pie, stuffing, and mac 'n' cheese without overdoing it. 'Food obsessions are history,' Bond shared after losing 122 pounds. 'I cherish the present.'
As we wrap up, it's clear GLP-1 drugs are reshaping holiday traditions for many, blending health with festivity. Yet, debates rage: Are these medications empowering true joy, or do they foster unrealistic expectations? Could skipping doses occasionally be a harmless strategy, or detrimental long-term? And what about the ethical side—should society prioritize access over costs? We'd love to hear your thoughts: Do you agree these drugs are a holiday lifeline, or do they complicate celebrations? Share in the comments—let's discuss!
